

Related Companies | [] | ||||||||
Related Funds | [] | ||||||||
English | |||||||||
oda_WinningATenderAbstract| |
| ||||||||
oda_UpdateAnnouncementFlag| |
| Hayır (No) | |||||||
oda_CorrectionAnnouncementFlag| |
| Hayır (No) | |||||||
oda_DateOfThePreviousNotificationAboutTheSameSubject| |
| - | |||||||
oda_DelayedAnnouncementFlag| |
| Hayır (No) | |||||||
oda_AnnouncementContentSection| |
| ||||||||
oda_SubjectOfTender| |
| 2027 Tender for Chemotherapy Supplies | |||||||
oda_PartyOpenedTender| |
| Dokuz Eylül University Rectorate, University Hospital and Research Center | |||||||
oda_BoardDecisionOnBidForTender| |
| 2026/38 | |||||||
oda_OtherPartiesIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_ShareOfTheCompanyIfParticipatedInTheTenderAsAGroup| |
| - | |||||||
oda_DateOfTenderBid| |
| 26/10/2026 | |||||||
oda_EndingUpDateOfTheTender| |
| ||||||||
oda_TenderResult| |
| - | |||||||
oda_TenderValue| |
| - | |||||||
oda_ShareOfCompanyInTenderValue| |
| - | |||||||
oda_RatioOfTenderValueCorporateShareAmountToGrossSalesRevenueOnPubliclyDisclosedTheLatestFinancialStatementOfCompany| |
| - | |||||||
oda_ExplanationSection| |
| ||||||||
oda_ExplanationTextBlock| | Our Company participated in the tender titled "2027 Chemotherapy Supplies", held on October 26, 2026, by the Dokuz Eylül University Rectorate, University Hospital and Research Center. Should the tender be awarded in our favor, developments regarding the process will be disclosed to the public and our investors. Respectfully announced to the public. The English translation of this disclosure is being prepared simultaneously. In the event of any discrepancy between the Turkish and English versions, the Turkish version shall prevail. | ||||||||
We proclaim that our above disclosure is in conformity with the principles set down in “Material Events Communiqué” of Capital Markets Board, and it fully reflects all information coming to our knowledge on the subject matter thereof, and it is in conformity with our books, records and documents, and all reasonable efforts have been shown by our Company in order to obtain all information fully and accurately about the subject matter thereof, and we’re personally liable for the disclosures.